China-based contract development and manufacturing organization (CDMO) Apeloa Pharmaceutical Co., Ltd (SHE: 000739) has announced a strategic partnership with CORXEL, formerly known as Ji Xing Pharmaceuticals. The financial details of the agreement have not been disclosed, but it is confirmed that Apeloa will provide professional CDMO services to CORXEL on a long-term basis.
Enhancing Pharmaceutical Development and Manufacturing
This partnership highlights the growing collaboration within the Chinese pharmaceutical industry. Apeloa Pharmaceutical, with its expertise in CDMO services, will support CORXEL in their pharmaceutical development and manufacturing endeavors. The long-term agreement is expected to enhance operational efficiency and contribute to the innovation and growth of the pharmaceutical sector in China.
Long-Term Commitment to Pharmaceutical Excellence
The long-term nature of the partnership between Apeloa and CORXEL underscores their mutual commitment to driving excellence in pharmaceutical development. Apeloa’s provision of CDMO services is set to bolster CORXEL’s capabilities, potentially accelerating the timeline for bringing new products to market and improving the overall pharmaceutical offering in the region.-Fineline Info & Tech
